Related Experiment Video
Updated: Jul 6, 2026

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
Published on: April 4, 2016
Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets
Chun Shi1, Kaihua Guo, David T Yew
1Department of Anatomy, Zhongshan School of Medicine, Sun Yat-Sen University Guangzhou, Guangdong 510080, China.
Abstract:
Mitochondrial dysfunction may play an important role in the pathogenesis of ageing and age-neurodegenerative diseases such as Alzheimer's disease (AD). Platelet mitochondrial membrane potential (reflected by measurement of JC-1 fluorescence ratio) and adenosine 5'-triphosphate (ATP) contents of 24 moderate probable AD patients, 20 age-matched control subjects and 20 young control subjects were measured. Also, a beta-amyloid peptide (Abeta)-induced damage model of platelets was established. After the addition of Abeta, platelet JC-1 fluorescence ratio and ATP content of platelets were measured in 16 AD patients, 20 aged and 20 young control subjects. Young control subjects had higher JC-1 fluorescence ratio than both AD patients and aged control subjects. No significant differences in platelet ATP contents were found among AD patients, aged and young control subjects. After the addition of Abeta, platelet JC-1 fluorescence ratio and ATP content of aged and young control subjects lowered markedly, but no obvious decrease of platelet JC-1 fluorescence ratio of AD patients was found compared with those of aged and young control subjects. Decrease of platelet JC-1 fluorescence ratio of aged control subjects was lower than that of young control subjects following the addition of Abeta. These results indicated that mitochondrial dysfunction may occur during ageing and platelet mitochondria of AD patients and aged subjects showed a tolerance to Abeta-induced damage. Therefore, blood platelets might serve as a biomarker for detection of mitochondrial function and age-related disease.
Insights
Platelet mitochondrial function declines with age and Alzheimer's disease (AD). However, AD patient and aged platelets show resistance to amyloid-beta damage, suggesting platelets as potential biomarkers for aging and neurodegenerative diseases.
Area of Science:
- Mitochondrial biology
- Neurodegenerative disease research
- Biomarker discovery
Background:
- Mitochondrial dysfunction is implicated in aging and neurodegenerative diseases like Alzheimer's disease (AD).
- Platelets, easily accessible blood components, contain mitochondria and can be studied for cellular health.
- Assessing mitochondrial membrane potential and ATP levels in platelets offers insights into cellular energy metabolism and dysfunction.
Purpose of the Study:
- To investigate mitochondrial function in platelets of Alzheimer's disease (AD) patients and aged individuals.
- To examine the impact of beta-amyloid peptide (Abeta) on platelet mitochondrial function.
- To determine the potential of blood platelets as biomarkers for aging and AD-related mitochondrial dysfunction.
Main Methods:
- Measurement of platelet mitochondrial membrane potential using JC-1 fluorescence ratio.
- Quantification of platelet adenosine 5'-triphosphate (ATP) content.
- Establishment of an Abeta-induced platelet damage model for comparative analysis.
Main Results:
- Younger individuals exhibited higher platelet mitochondrial membrane potential compared to AD patients and aged controls.
- Platelet ATP levels did not significantly differ across young, aged, and AD groups.
- Abeta exposure significantly reduced mitochondrial potential and ATP in young and aged platelets, but not in AD patient platelets, indicating resistance to Abeta-induced damage.
- Aged platelets showed less reduction in mitochondrial potential than young platelets after Abeta exposure.
Conclusions:
- Mitochondrial dysfunction is associated with the aging process.
- Platelet mitochondria in AD patients and aged individuals display a tolerance to Abeta-induced damage.
- Blood platelets may serve as valuable biomarkers for assessing mitochondrial function and age-related diseases, including Alzheimer's disease.
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Alzheimer Disease l: Introduction
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Mitochondrial Membranes
Alzheimer Disease ll: Pathophysiology
